BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33403460)

  • 1. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
    Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
    Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
    Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
    J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.
    Bonekamp D; Wolf MB; Roethke MC; Pahernik S; Hadaschik BA; Hatiboglu G; Kuru TH; Popeneciu IV; Chin JL; Billia M; Relle J; Hafron J; Nandalur KR; Staruch RM; Burtnyk M; Hohenfellner M; Schlemmer HP
    Eur Radiol; 2019 Jan; 29(1):299-308. PubMed ID: 29943185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies.
    Siddiqui K; Chopra R; Vedula S; Sugar L; Haider M; Boyes A; Musquera M; Bronskill M; Klotz L
    Urology; 2010 Dec; 76(6):1506-11. PubMed ID: 20709381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review.
    Dora C; Clarke GM; Frey G; Sella D
    J Endourol; 2022 Jun; 36(6):841-854. PubMed ID: 35029127
    [No Abstract]   [Full Text] [Related]  

  • 9. MR-guided biopsy and focal therapy: new options for prostate cancer management.
    Elkhoury FF; Simopoulos DN; Marks LS
    Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-Guided Prostate Interventions.
    Woodrum DA; Gorny KR; Mynderse LA
    Top Magn Reson Imaging; 2018 Jun; 27(3):141-151. PubMed ID: 29870466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Review.
    Chaussy CG; Thüroff S
    J Endourol; 2017 Apr; 31(S1):S30-S37. PubMed ID: 28355119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
    Mäkelä P; Anttinen M; Suomi V; Steiner A; Saunavaara J; Sainio T; Horte A; Taimen P; Boström P; Blanco Sequeiros R
    Acta Radiol; 2021 Dec; 62(12):1687-1695. PubMed ID: 33251811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Imaging-Guided Prostate Cancer Therapies.
    Adamo DA; Greenwood BM; Ghanouni P; Arora S
    Radiol Clin North Am; 2024 Jan; 62(1):121-133. PubMed ID: 37973238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters.
    Hatiboglu G; Popeneciu V; Bonekamp D; Burtnyk M; Staruch R; Pahernik S; Tosev G; Radtke JP; Motsch J; Schlemmer HP; Hohenfellner M; Nyarangi-Dix JN
    World J Urol; 2020 Feb; 38(2):343-350. PubMed ID: 31062122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA).
    Lumiani A; Samun D; Sroka R; Muschter R
    Urol Oncol; 2021 Dec; 39(12):830.e9-830.e16. PubMed ID: 34144892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer.
    Klotz L; Pavlovich CP; Chin J; Hatiboglu G; Koch M; Penson D; Raman S; Oto A; Fütterer J; Serrallach M; Relle J; Lotan Y; Heidenreich A; Bonekamp D; Haider M; Tirkes T; Arora S; Macura KJ; Costa DN; Persigehl T; Pantuck AJ; Bomers J; Burtnyk M; Staruch R; Eggener S
    J Urol; 2021 Mar; 205(3):769-779. PubMed ID: 33021440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
    Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
    Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
    Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
    Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
    Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.